Results 91 to 100 of about 3,769 (208)

ePoster

open access: yes
European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Ambroxol Therapy as an Antibiofilm Candidate in Diabetic Ulcer Patients

open access: yes
Patients with diabetic ulcers are susceptible to infection because the tissue in their extremities is constantly exposed to various pathogenic bacteria, so biofilm formation plays an important role in developing the disease.
Nuryastuti, Titik   +3 more
core   +1 more source

Mucolytic Drugs Ambroxol and Bromhexine: Transformation under Aqueous Chlorination Conditions

open access: yes
Bromhexine and ambroxol are among the mucolytic drugs most widely used to treat acute and chronic respiratory diseases. Entering the municipal wastewater and undergoing transformations during disinfection with active chlorine, these compounds can produce
Sergey A. Sypalov   +4 more
core   +1 more source

A 10-year follow-up of high-dose ambroxol treatment combined with enzyme replacement therapy for neuropathic Gaucher disease

open access: yes
High-dose ambroxol therapy combined with ERT in patients with neuropathic Gaucher ...
Beom Hee Lee   +10 more
core   +1 more source

Biofilm-dependent airway infections: a role for ambroxol?

open access: yes, 2014
Biofilms are a key factor in the development of both acute and chronic airway infections. Their relevance is well established in ventilator associated pneumonia, one of the most severe complications in critically ill patients, and in cystic fibrosis, the
CATALDI, MAURO   +3 more
core   +1 more source

Impact of mycolytic therapy on the production of active oxygen formS in the blood of patients with an exacerbation of chronic obstructive pulmonary disease

open access: yesТерапевтический архив, 2010
Aim. To study the production of active oxygen forms (AOF) in the blood of patients with an exacerbation of chronic obstructive pulmonary disease (COPD) and the effect of the mycolytic agent Ambroxol on this process. Subjects and methods.
Usman Raul'evich Farkhutdinov   +9 more
doaj  

Mucoactive therapy with ambroxol in patients with productive cough: time to target the key mechanisms. A review

open access: yesConsilium Medicum
Ambroxol is one of the best studied mucoactive agents used in respiratory diseases associated with productive cough, mucus hypersecretion, and impaired mucociliary clearance.
Sergei L. Babak   +3 more
doaj   +1 more source

The efficacy of nebulized budesonide and ambroxol hydrochloride in treating pediatric community-acquired pneumonia and their impact on clinical characteristics and inflammatory markers

open access: yesJournal of Health, Population and Nutrition
Purpose To evaluate the therapeutic efficacy of intravenous amoxicillin clavulanate potassium combined with nebulized budesonide and ambroxol hydrochloride in pediatric community-acquired pneumonia (CAP) and its impact across various microbial strains ...
Xiaoqin Zhang   +4 more
doaj   +1 more source

Clinical efficacy and safety of high-dose ambroxol in the form of oromucosal spray in postnasal drip syndrome: results of a multicenter study in Ukraine

open access: yesMedičnì Perspektivi
Postnasal drip syndrome (PNDS) is one of the most common clinical conditions in the practice of otolaryngologists and family physicians, characterized by the drainage of mucous or mucopurulent secretions along the posterior wall of the pharynx and ...
Yu.V. Deeva , et al. co-authors
doaj   +1 more source

Clinical efficacy of ambroxol combined with cefoperazone sodium and sulbactam sodium in the treatment of senile severe pneumonia

open access: yesGuoji laonian yixue zazhi
[Objective] To investigate the clinical efficacy of ambroxol combined with cefoperazone sodium and sulbactam sodium in the treatment of elderly patients with severe pneumonia.
Lu Qiuying   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy